InterCure Ltd. (NASDAQ:INCR – Get Free Report) was the recipient of a large drop in short interest during the month of October. As of October 31st, there was short interest totalling 13,900 shares, a drop of 21.9% from the October 15th total of 17,800 shares. Based on an average daily trading volume, of 28,600 shares, the short-interest ratio is presently 0.5 days. Currently, 0.1% of the company’s shares are sold short.
InterCure Stock Down 5.9 %
Shares of INCR stock traded down $0.07 on Friday, reaching $1.17. 142,958 shares of the stock were exchanged, compared to its average volume of 37,305. The company has a current ratio of 1.78, a quick ratio of 1.15 and a debt-to-equity ratio of 0.15. InterCure has a one year low of $1.06 and a one year high of $3.72. The stock has a 50 day moving average price of $1.76 and a 200 day moving average price of $2.21.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in the business. Tidal Investments LLC acquired a new stake in shares of InterCure during the 1st quarter worth approximately $883,000. AdvisorShares Investments LLC acquired a new stake in InterCure during the 2nd quarter worth $218,000. Jane Street Group LLC acquired a new stake in InterCure during the 3rd quarter worth $49,000. Finally, Renaissance Technologies LLC raised its position in shares of InterCure by 30.9% during the 2nd quarter. Renaissance Technologies LLC now owns 45,300 shares of the company’s stock valued at $91,000 after acquiring an additional 10,700 shares during the last quarter. 8.34% of the stock is currently owned by institutional investors and hedge funds.
InterCure Company Profile
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.
Further Reading
- Five stocks we like better than InterCure
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Stock Analyst Ratings and Canadian Analyst Ratings
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Quiet Period Expirations Explained
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.